Heterogeneity of molecular sensitization profiles in grass pollen allergy - implications for immunotherapy?

Clinical and Experimental Allergy

Volumn 44, Issue 5, 2014, Pages 778-786

  Darsow, U ^a   Brockow, K ^a   Pfab, F ^a   Jakob, T ^b   Petersson, C J ^c   Borres, M P ^c,d   Ring, J ^a   Behrendt, H ^a   Huss Marp, J ^b,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Thermo Fisher Scientific   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

^e THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Allergenic molecules; Combinatorial analysis; Component resolved diagnosis; Component resolved therapy; Hay fever; Molecular allergy diagnostics; Nasal conjunctival provocation test; Phleum pratense; Specific IgE; Timothy

Indexed keywords

IMMUNOGLOBULIN E; POLLEN ANTIGEN; ALLERGEN; VEGETABLE PROTEIN; HOUSE DUST ALLERGEN;

ADULT; ARTICLE; ATOPY; CONJUNCTIVAL PROVOCATION TEST; FEMALE; GRASS POLLEN; HUMAN; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NOSE PROVOCATION TEST; OUTCOME ASSESSMENT; PHLEUM PRATENSE; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION; BLOOD; DESENSITIZATION; IMMUNOLOGY; POACEAE; POLLEN; PROTEIN MICROARRAY; RHINITIS, ALLERGIC, SEASONAL; ARTEMISIA VULGARIS; BIRCH; CONJUNCTIVA; CONTROLLED STUDY; DERMATOPHAGOIDES; HAZELNUT; MOLECULAR DIAGNOSTICS; MOLECULAR SENSITIZATION; PREDICTIVE VALUE;

ADULT; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; PHLEUM; PLANT PROTEINS; POACEAE; POLLEN; PROTEIN ARRAY ANALYSIS; RHINITIS, ALLERGIC, SEASONAL;

EID: 84912129527     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12303     Document Type: Article

References (30)

1. Huss-Marp J, Darsow U, Brockow K et al. Can Immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? Clin Exp Allergy 2011; 41:1116-24.
2. Hamilton RG. Provocation tests with objective measures remain more diagnostic than surrogate immunoglobulin E antibody measures of sensitization. Clin Exp Allergy 2011; 41:1048-9.
3. Christensen LH, Holm J, Lund G, Riise E, Lund K. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol 2008; 122:298-304.
4. Nicolaou N, Poorafshar M, Murray C et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010; 125:e1-13.
5. Custovic A, Nicolaou N. Peanut allergy: overestimated in epidemiology or underdiagnosed in primary care? J Allergy Clin Immunol 2011; 127:631-2.
6. Dang TD, Tang M, Choo S et al. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J Allergy Clin Immunol 2012; 129:1056-63.
7. Eller E, Bindslev-Jensen C. Clinical value of component-resolved diagnostics in peanut-allergic patients. Allergy 2013; 68:190-4.
8. Masthoff LJ, Mattsson L, Zuidmeer-Jongejan L et al. Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. J Allergy Clin Immunol 2013; 132:393-9.
9. Casale TB, Stokes JR. Future forms of immunotherapy. J Allergy Clin Immunol 2011; 127:8-15; quiz 6-7.
10. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005; 116:608-13.
11. Pauli G, Larsen TH, Rak S et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008; 122:951-60.
12. Tripodi S, Frediani T, Lucarelli S et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol 2012; 129:e8.
13. Malm L, Gerth van Wijk R, Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. Rhinology 2000; 38:1-6.
14. Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 2003; 130:87-107.
15. Hatzler L, Panetta V, Lau S et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130:e5.
16. Rossi RE, Monasterolo G, Monasterolo S. Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen. Allergy 2001; 56:1180-5.
17. Mari A. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003; 33:43-51.
18. Suck R, Hagen S, Cromwell O, Fiebig H. The high molecular mass allergen fraction of timothy grass pollen (Phleum pratense) between 50-60 kDa is comprised of two major allergens: Phl p 4 and Phl p 13. Clin Exp Allergy 2000; 30:1395-402.
19. Nopp A, Johansson SG, Lundberg M, Oman H. Simultaneous exposure of several allergens has an additive effect on multisensitized basophils. Allergy 2006; 61:1366-8.
20. Hamilton RG, Williams PB. Human IgE antibody serology: a primer for the practicing North American allergist/immunologist. J Allergy Clin Immunol 2010; 126:33-8.
21. Willumsen N, Holm J, Christensen LH, Wurtzen PA, Lund K. The complexity of allergic patients' IgE repertoire correlates with serum concentration of allergen-specific IgE. Clin Exp Allergy 2012; 42:1227-36.
22. Gosepath J, Amedee RG, Mann WJ. Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. Laryngoscope 2005; 115:512-6.
23. Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST. Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006; 36:1488-93.
24. Garcia-Ortega P, Costa B, Richart C. Evaluation of the conjunctival provocation test in allergy diagnosis. Clin Exp Allergy 1989; 19:529-32.
25. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896-904.
26. Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2002; 2:446-53.
27. Moverare R, Elfman L, Vesterinen E, Metso T, Haahtela T. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002; 57:423-30.
28. Gronlund H, Gafvelin G. Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen. Hum Vaccin 2010; 6:970-7.
29. Stringari G, Tripodi S, Caffarelli C et al. The impact of component resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol 2014; doi: 10.1016/j.jaci.2013.12.186 [Epub ahead of print].
30. Scala E, Alessandri C, Bernardi ML et al. Cross-sectional survey on immunoglobulin E reactivity in 23, 077 subjects using an allergenic molecule-based microarray detection system. Clin Exp Allergy 2010; 40:911-21.